Alexandros Makriyannis

Northeastern University

NIH Rank #5921
  • Program Leader
  • R01 Holder
  • Translational
  • Early Career
  • Mentor
  • Diverse Portfolio

NIH Funding · FY2024

Total Funding
$1.9M
Fiscal year 2024
Grants Awarded
5
Active NIH grants
National Rank
#5,921
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $1.9M across 5 grants · National rank #5921.

Top grants by award amount

Alexandros Makriyannis's NIH grant portfolio, ranked by award amount.

  • 5U01AA028963-05U01
    CB1 Neutral Antagonists for Alcohol Use Disorder
    $1.2M
    award amount
  • 5R01DA052271-05R01
    Targeting Inflammasome with stable endocannabinoid ligand AMG315. CRISPR/Cas9 and nanotechnology study in the context of HIV and cannabinoid
    $370.3K
    award amount
  • 5T32DA055553-03T32
    Training Program on Development of Medications for Substance Use Disorder
    $224.7K
    award amount
  • 5P01DA009158-22P01
    Endocannabinoid Active Sites as Therapeutic Targets
    $90K
    award amount
  • 5R13DA040423-10R13
    Chemistry and Pharmacology of Drugs of Abuse Annual Symposium
    $25K
    award amount

Affiliations

Institutions that have administered grants for Alexandros Makriyannis.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Northeastern University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #5921
  5. 2024
    Multi-Institutional Research
    Awards at 2 institutions